Chitosan (MW 30000)

CAT:
804-HY-B2144B
Size:
500 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Chitosan (MW 30000) - image 1

Chitosan (MW 30000)

  • UNSPSC Description:

    Chitosan (MW 30000) (Deacetylated chitin (MW 30000)) is a polycationic linear polysaccharide derived from chitin with the molecular weight of 30000. Chitosan is an versatile biomaterial because of its non-toxicity, low allergenicity, biocompatibility and biodegradability. Chitosan also has antitumor, antibacterial, antifungal, and antioxidant activities[1][2].
  • Target Antigen:

    Bacterial; Fungal
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Cancer; Infection
  • Assay Protocol:

    https://www.medchemexpress.com/chitosan-mw-30000.html
  • Solubility:

    0.1 M HCL : 5 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : < 0.1 mg/mL
  • Smiles:

    OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](N)[C@H](O[C@H]3[C@H](O)[C@@H](N)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.[n].[MW 30000]
  • Molecular Weight:

    501.48
  • References & Citations:

    [1]Laure Gibot, et al. Anticancer properties of chitosan on human melanoma are cell line dependent. Int J Biol Macromol. 2015 Jan;72:370-9.|[2]Randy Chi Fai Cheung, et al. Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications. Mar Drugs. 2015 Aug 14;13(8):5156-86.|[3]Shyr-Yi Lin, et al. Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis. J Cell Biochem. 2007 Apr 15;100(6):1573-80.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    9012-76-4